Perioperative duloxetine as part of a multimodal analgesia regime reduces postoperative pain in lumbar canal stenosis surgery: a randomized, triple blind, and placebo-controlled trial
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Duloxetine is an antidepressant that is also useful in chronic neuropathic and central origin pain. In this study, the role of duloxetine in decreasing acute postoperative pain after lumbar canal stenosis surgery is explored. Methods: In this single center, triple blinded, and placebo-controlled trial, 96 patients were randomized for statistical analysis. The intervention group received oral duloxetine 30 mg once a day (OD) for 2 days before surgery, 60 mg OD from the day of surgery to the postoperative second day and 30 mg OD for the next 2 days (a total duration of 7 days). A placebo capsule was given in the other group for a similar time and schedule. The same standard perioperative analgesia protocols were followed in both groups. Results: Total morphine consumption up to 24 hours was significantly decreased in the duloxetine group (P < 0.01). The time to the first analgesia requirement was similar in both groups but the time to the second and third dose of rescue analgesia increased significantly in the duloxetine group. The time to ambulation was decreased significantly (P < 0.01) in the duloxetine group as compared to the placebo group. Pain scores remained similar during most of the time interval. No significant difference was observed in the complication rate and patient satisfaction score recorded. Conclusions: Duloxetine reduces postoperative pain after lumbar canal stenosis surgery with no increase in adverse effects.
Abstract
Background: Duloxetine is an antidepressant that is also useful in chronic neuropathic and central origin pain. In this study, the role of duloxetine in decreasing acute postoperative pain after lumbar canal stenosis surgery is explored. Methods: In this single center, triple blinded, and placebo-controlled trial, 96 patients were randomized for statistical analysis. The intervention group received oral duloxetine 30 mg once a day (OD) for 2 days before surgery, 60 mg OD from the day of surgery to the postoperative second day and 30 mg OD for the next 2 days (a total duration of 7 days). A placebo capsule was given in the other group for a similar time and schedule. The same standard perioperative analgesia protocols were followed in both groups. Results: Total morphine consumption up to 24 hours was significantly decreased in the duloxetine group (P < 0.01). The time to the first analgesia requirement was similar in both groups but the time to the second and third dose of rescue analgesia increased significantly in the duloxetine group. The time to ambulation was decreased significantly (P < 0.01) in the duloxetine group as compared to the placebo group. Pain scores remained similar during most of the time interval. No significant difference was observed in the complication rate and patient satisfaction score recorded. Conclusions: Duloxetine reduces postoperative pain after lumbar canal stenosis surgery with no increase in adverse effects.
참고문헌 (18)
- Bajwa SJ, "Pain management following spinal surgeries : an appraisal of the available options", J Craniovertebr Junction Spine, 6, pp.105~110 (2015)
- Sang Wook Shin, "Antipsychotics for patients with pain", The Korean Journal of Pain, 32(1), pp.3~11 (2019), 대한통증학회[DOI]
- Samuel Vilar, "Therapeutic alternatives in painful diabetic neuropathy: a meta-analysis of randomized controlled trials", The Korean Journal of Pain, 31(4), pp.253~260 (2018), 대한통증학회
- Turan A, "Analgesic effects of gabapentin after spinal surgery", Anesthesiology, 100, pp.935~938 (2004)
- Onuţu AH, "Duloxetine, an antidepressant with analgesic properties-a preliminary analysis", Rom J Anaesth Intensive Care, 22, pp.123~128 (2015)
- Sun YH, "The analgesia effect of duloxetine on post-operative pain via intrathecal or intraperitoneal administration", Neurosci Lett, 568, pp.6~11 (2014)
- Schukro RP, "Efficacy of duloxetine in chronic low back pain with a neuropathic component : a randomized, double-blind, placebo-controlled crossover trial", Anesthesiology, 124, pp.150~158 (2016)
- Castro-Alves LJ, "Perioperative duloxetine to improve postoperative recovery after abdominal hysterectomy", Surv Anesthesiol, 60, pp.171~172 (2016)
- Gilron I, "Antidepressant drugs for postsurgical pain : current status and future directions", Drugs, 76, pp.159~167 (2016)
- Ho KY, "Duloxetine reduces morphine requirements after knee replacement surgery", Br J Anaesth, 105, pp.371~376 (2010)
- YaDeau JT, "Duloxetine and subacute pain after knee arthroplasty when added to a multimodal analgesic regimen : a randomized, placebo-controlled, triple-blinded trial", Anesthesiology, 125, pp.561~572 (2016)
- Jacobs MB, "Duloxetine for subacute pain management after total knee arthroplasty: should we write it off or reevaluate?", Anesthesiology, 125, pp.454~456 (2016)
- Smith EM, "Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy : a randomized clinical trial", JAMA, 309, pp.1359~1367 (2013)
- Castro-Alves LJ, "Perioperative duloxetine to improve postoperative recovery after abdominal hysterectomy : a prospective, randomized, double-blinded, placebo-controlled study", Anesth Analg, 122, pp.98~104 (2016)
- Minami K, "Effects of duloxetine on pain and walking distance in neuropathic pain models via modulation of the spinal monoamine system", Eur J Pain, 22, pp.355~369 (2018)
- Altiparmak B, "Comparison of preoperative administration of pregabalin and duloxetine on cognitive functions and pain management after spinal surgery : a randomized, double-blind, placebo-controlled study", Clin J Pain, 34, pp.1114~1120 (2018)
- Kiso T, "Effects of pregabalin and duloxetine on neurotransmitters in the dorsal horn of the spinal cord in a rat model of fibromyalgia", Eur J Pharmacol, 827, pp.117~124 (2018)
- Shen F, "Relative contributions of norepinephrine and serotonin transporters to antinociceptive synergy between monoamine reuptake inhibitors and morphine in the rat formalin model", PLoS One, 8, pp.e74891~ (2013)